7 Health Ventures Invests in Tul... (in September 2007 hadinvested in 4 compa...)

(Date:11/25/2009)...therlandsandJOHANNESBURG,November25/PRNewswire/--,...overyannouncedtoday,thattheyhavesignedacollaborati... , Pyxis,sworldclasscomputationalchemistryand...ervicedivisiontoprovidemedicinaland,syntheticchemi...nationalclientnetwork.iThembaPharmaceuticalsandPyx...

(Date:11/24/2009)...Nov.24/PRNewswire/-- ,, WHAT:RomHoubens,aBelgia...toaccident,wasactuallyfullyconsciousandawakeduring...nt.TheDynaVoxEyeMaxwasfeaturedinthesegmenttoillust...nscanunlockcommunication. ,, WHEN:GoodMorningAm...w.dynavoxtech.com ,, WHO:RomHoubenswasaneng...

(Date:11/24/2009)...v.24/PRNewswire-FirstCall/--AnadysPharmaceuticals,...atthe21stAnnualPiperJaffrayHealthcareConferenceonT...econferenceisbeingheldatTheNewYorkPalaceHotel.Stev...Anadys,willprovideanoverviewofAnadysanditsclinical...oratepresentationwillbesimultaneouslywebcastandcan...

Breaking Medicine Technology:iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2 DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2 Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2 Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 1 Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 2 Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 3 Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 4 Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 5 WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 1 WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 2 WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 3 Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 1 Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 2 Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 3

[0] iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering [0] DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years [0] Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference

...NCOUVER, June 21, 2007 /PRNewswire-FirstCall/ - Bi...ederation has given,Biotech,s "Sucanon" diabetes d...ublished in the May-June 2007 issue of Diabetes,Ho...l magazine for,doctors and other health profession...Dr. Roberto Cepeda,Gonzalez, Medical Director of t...

...COLNSHIRE, Ill.--(BUSINESS WIRE)--Jun 21, 2007 - B...vided comment on the,Women,s Health Initiative (WH...ay in The New England Journal of Medicine (NEJM).,...d 50-59) who,received a standard dose of estrogen ...cification at the end of the study period,compared...

Other Medicine Technology:Diabetes drug supported by Mexican Diabetes Federation 2 Diabetes drug supported by Mexican Diabetes Federation 3 New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 2 New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 3 New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 4

Diabetes drug supported by Mexican Diabetes Federation New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy

(Date:11/26/2009)...tions announces a highly effective and unconventio...g to make an economic recovery. , ... the type of challenge that could send ailing holi...David Benton, business growth expert and author of... The Rfactor Intensive . “Fear is one of ...

(Date:11/25/2009)...e-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: O...oreventsinDecember: ,, ASHBriefing ,, ...cipalinvestigatorswilldiscussdatapresentationssurr...lemyeloma,asfeaturedatthe51stAmericanSocietyofHema...LA.Theteleconferencewillbeginat9:00a.m.CT/10:00a.m...

(Date:11/25/2009)...-USNewswire/--AnarticlebyJanetWoodcock,M.D.,direct...led"ADifficultBalance-PainManagement,DrugSafety,an...ndJournalofMedicine. ,, (Logo: http://www.newsc...article,WoodcockdiscussesFDAeffortstostrikeabalanc...managingtherisksposedbyvariousanalgesics.Asexample...

(Date:11/25/2009)... who were treated with cisplatin-based chemotherap...ical side effects and Raynaud-like phenomena, than...ding to a new study published online November 25 i..., Marianne Brydy, M.D., of the Department of Onc...orway, and colleagues conducted a cross-sectional ...

(Date:11/25/2009)...o draw definite conclusions, experts say, , ...iabetic patients with blocked coronary arteries, t...e year whether patients undergo bypass surgery or ...ort. , Bypass surgery has been the standard tre...disease. However, less invasive approaches such as...

Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2 Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2 Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2 Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3

[0] Pharmacist Injects Cure for Ailing Businesses [0] Onyx Pharmaceuticals Announces December 2009 Investor Events [1] FDA's Woodcock Discusses Pain Management and Drug Safety in Nov. 26, 2009 Issue of The New England Journal of Medicine [0] News brief: Long-term testicular cancer survivors at high risk for neurological side effects [1] Stenting May Equal Bypass for Diabetic Heart Patients

...common, naturally occurring virus that attacks can...ls is being studied as a possible treatment for ma... called gliomas. Researchers at Cedars-Sinai Medic...the virus in its natural state. It commonly infect...

...and African plants are being used by Queensland re...o treat chronic pain. , Professor David Craik an...r Bioscience have received $218,275 from the Natio...he molecule they have developed have shown that it...

...mon and severe symptom reported by middle-aged wom... into the menopause, according to a study in the A...sing. , Researchers at the University of Arizona ...s. Their average age was 49 and they had all exper...

...Xinhua-PRNewswire-FirstCall/ --,China RuiTai Inter...RUI),(,China RuiTai, or ,the Company,), a leading ...ts in the People,s Republic of China (,PRC,),today...n -- Gross profit increased 33.4% to $11.9 millio...

...rience in both healthcare and human ...Precyse Solutions, the leader in,driving peak perf...,departments, today announced the appointment of K...f Human Resources,and Administration. With over 25...

...verwhelmingly want their next President to focus m...ng universal healthcare, and stemming the,outsourc...igrants to live,and work in the U.S., according to...ing of 1,125 working,Americans between April 4 and...

Cedars-Sinai Medical Center opens patient trial of virus that attacks brain cancer cells Cone snails and plants used to develop oral drug for pain Getting a good night's sleep is the biggest problem for women entering the menopause China RuiTai Reports Fiscal Year 2007 Financial Results Precyse Solutions Appoints Karen Heisler as New Corporate Vice President, Human Resources Americans Want Next President to Focus More on Saving U.S. Jobs and Healthcare; Less on Immigration Reform

...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...

Medicine Products:

Norepinephrine, Plasma Nonspecific Circulating Anticoagulant Inhibitor PT Nonfermenter Susceptibility Panel Noludar

7 Health Ventures Invests in Tul...(in September 2007 hadinvested in 4 compa...),Health